martes, 24 de diciembre de 2013

National Guideline Clearinghouse | Radionuclide therapy for neuroendocrine malignancies. Cancer Care Ontario

full-text ►
National Guideline Clearinghouse | Radionuclide therapy for neuroendocrine malignancies.


Cancer Care Ontario 
National Guideline Clearinghouse (NGC)

December 23, 2013


New This Week


Guideline Title

Radionuclide therapy for neuroendocrine malignancies.

Bibliographic Source(s)
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C, Radionuclide Therapy for Neuroendocrine Tumours Expert Panel. Radionuclide therapy for neuroendocrine malignancies. Toronto (ON): Cancer Care Ontario (CCO); 2011 Aug 15. Various p. (Evidence-based series; no. 12-13).  [90 references]

Guideline Status

This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.
Please visit the Cancer Care Ontario Web site External Web Site Policy for details on any new evidence that has emerged and implications to the guidelines.

No hay comentarios:

Publicar un comentario